SLS · SELLAS Life Sciences Group, Inc.
AI read · Good for SLS
The AI's read
The results give GPS evidence that it can help patients live longer than the treatments used for comparison. This could strengthen SELLAS's case with the FDA, but approval has not been granted. The company still plans to discuss a possible path with the agency and prepare an application.